MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

Search

Prestige Consumer Healthcare

Geschlossen

BrancheGesundheitswesen

65.04 -0.73

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

64.82

Max

65.23

Schlüsselkennzahlen

By Trading Economics

Einkommen

-5.3M

42M

Verkäufe

25M

274M

KGV

Branchendurchschnitt

16.163

90.831

Gewinnspanne

15.399

Angestellte

600

EBITDA

7.2M

87M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+22.08% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

5. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

232M

3.2B

Vorheriger Eröffnungskurs

65.77

Vorheriger Schlusskurs

65.04

Nachrichtenstimmung

By Acuity

50%

50%

138 / 361 Ranking in Healthcare

Prestige Consumer Healthcare Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

16. Jan. 2026, 23:29 UTC

Heiße Aktien

Stocks to Watch: Atossa Therapeutics, Union Pacific

18. Jan. 2026, 23:57 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Standalone Plan Offers Clear Path to Valuation of More Than Y40,000 a Share by 2028

18. Jan. 2026, 23:57 UTC

Akquisitionen, Fusionen, Übernahmen

Elliott: Opposing Toyota Fudosan's Revised Tender Offer for Toyota Industries

18. Jan. 2026, 23:55 UTC

Market Talk

Oil Falls as Middle East Tensions Continue to Fade -- Market Talk

18. Jan. 2026, 23:40 UTC

Market Talk

Precious Metals Climb After Trump Threatens Europe With Tariffs Over Greenland -- Market Talk

18. Jan. 2026, 22:29 UTC

Market Talk

Miners Seen Extending Rally as Generalist Investors Warm to Sector -- Market Talk

18. Jan. 2026, 21:03 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18. Jan. 2026, 21:03 UTC

Market Talk

More Australian Voters Switch Away From Major Parties -- Market Talk

18. Jan. 2026, 19:46 UTC

Market Talk

FX Markets Taking Latest Trump Tariff Threat Calmly -- Market Talk

17. Jan. 2026, 15:06 UTC

Akquisitionen, Fusionen, Übernahmen

Trump Purchased Netflix, Warner Bonds in Days After Deal Announcement -- Update

17. Jan. 2026, 03:10 UTC

Akquisitionen, Fusionen, Übernahmen

Trump Purchased Netflix, Warner Bonds In Days After Deal Announcement -- WSJ

16. Jan. 2026, 22:48 UTC

Akquisitionen, Fusionen, Übernahmen

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- 2nd Update

16. Jan. 2026, 22:43 UTC

Akquisitionen, Fusionen, Übernahmen

Union Pacific: Additional Information Requested to Be Provided to Surface Transportation Board

16. Jan. 2026, 22:22 UTC

Akquisitionen, Fusionen, Übernahmen

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- Update

16. Jan. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

16. Jan. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Auto & Transport Roundup: Market Talk

16. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16. Jan. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

16. Jan. 2026, 21:48 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Union Pacific, Norfolk Southern Market Share Ruled as Faulty -- Market Talk

16. Jan. 2026, 21:41 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Union Pacific, Norfolk Southern Deal Rejection Leaves Questions -- Market Talk

16. Jan. 2026, 21:38 UTC

Akquisitionen, Fusionen, Übernahmen

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- WSJ

16. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

STB: Union Pacific, Norfolk Southern Application Doesn't Include 'Projected Market Shares' as Required

16. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

STB: Union Pacific, Norfolk Southern Application Doesn't Include Certain Schedules, Documents Expressly Made Part of Merger Agreement

16. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

STB: Union Pacific, Norfolk Southern Application Doesn't Contain Certain Information Required by Regulations

16. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

STB: Application Rejected Without Prejudice to Union Pacific, Norfolk Southern Refiling Revised Application Remedying Deficiencies

16. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

Surface Transportation Board: Union Pacific, Norfolk Southern Major Merger Application Filed Dec. 19 Incomplete

16. Jan. 2026, 20:44 UTC

Ergebnisse

5 Takeaways From This Season's Wealth Management Earnings -- Barrons.com

16. Jan. 2026, 20:42 UTC

Market Talk

Oil Futures Post Fourth Straight Weekly Gain -- Market Talk

16. Jan. 2026, 20:28 UTC

Market Talk

U.S. Natural Gas Slips Ahead of Long Weekend -- Market Talk

16. Jan. 2026, 19:12 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Netflix Could Comment on Structure of Warner Bid During 4Q Results -- Market Talk

Peer-Vergleich

Kursveränderung

Prestige Consumer Healthcare Prognose

Kursziel

By TipRanks

22.08% Vorteil

12-Monats-Prognose

Durchschnitt 79.5 USD  22.08%

Hoch 88 USD

Tief 71 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Prestige Consumer Healthcare – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

3

Buy

1

Halten

0

Sell

Stimmung

By Acuity

138 / 361 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
help-icon Live chat